# Ketamine for Veterans With Parkinson's Disease

> **NCT06231563** · PHASE2 · RECRUITING · sponsor: **VA Office of Research and Development** · enrollment: 80 (estimated)

## Conditions studied

- Parkinson's Disease

## Interventions

- **DRUG:** Ketamine
- **DRUG:** Remimazolam

## Key facts

- **NCT ID:** NCT06231563
- **Lead sponsor:** VA Office of Research and Development
- **Sponsor class:** FED
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-03-01
- **Primary completion:** 2029-09-30
- **Final completion:** 2029-09-30
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2026-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06231563

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06231563, "Ketamine for Veterans With Parkinson's Disease". Retrieved via AI Analytics 2026-08-03 from https://api.ai-analytics.org/clinical/NCT06231563. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*